- Home
- PRLD vs USIO Comparison
PRLD vs USIO Comparison
Compare PRLD & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- USIO
- Stock Information
- Founded
- PRLD 2016
- USIO 1998
- Country
- PRLD United States
- USIO United States
- Employees
- PRLD N/A
- USIO N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- USIO Investment Bankers/Brokers/Service
- Sector
- PRLD Health Care
- USIO Finance
- Exchange
- PRLD Nasdaq
- USIO Nasdaq
- Market Cap
- PRLD 44.0M
- USIO 50.2M
- IPO Year
- PRLD 2020
- USIO N/A
- Fundamental
- Price
- PRLD $1.01
- USIO $1.44
- Analyst Decision
- PRLD Strong Buy
- USIO Strong Buy
- Analyst Count
- PRLD 3
- USIO 1
- Target Price
- PRLD $4.00
- USIO $4.00
- AVG Volume (30 Days)
- PRLD 133.9K
- USIO 99.5K
- Earning Date
- PRLD 08-14-2025
- USIO 08-06-2025
- Dividend Yield
- PRLD N/A
- USIO N/A
- EPS Growth
- PRLD N/A
- USIO N/A
- EPS
- PRLD N/A
- USIO 0.11
- Revenue
- PRLD $7,000,000.00
- USIO $83,851,606.00
- Revenue This Year
- PRLD N/A
- USIO $16.02
- Revenue Next Year
- PRLD N/A
- USIO $13.24
- P/E Ratio
- PRLD N/A
- USIO $13.65
- Revenue Growth
- PRLD N/A
- USIO 2.05
- 52 Week Low
- PRLD $0.61
- USIO $1.24
- 52 Week High
- PRLD $5.95
- USIO $2.92
- Technical
- Relative Strength Index (RSI)
- PRLD 52.78
- USIO 39.16
- Support Level
- PRLD $0.75
- USIO $1.45
- Resistance Level
- PRLD $0.96
- USIO $2.02
- Average True Range (ATR)
- PRLD 0.08
- USIO 0.14
- MACD
- PRLD 0.01
- USIO -0.03
- Stochastic Oscillator
- PRLD 67.87
- USIO 11.72
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.